|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 1.805,00 GBX | -1,15% |
|
+0,78% | +34,05% |
| 05/12 | Vaccinproducenten uiten zorgen over koerswijziging VS-panel rond hepatitis B-prik voor pasgeborenen | RE |
| 05/12 | Shingelvaccin verlaagt sterfterisico door dementie, blijkt uit studie | RE |
Voorlopige winst- en verliesrekening: GSK plc
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 34.099 | 34.114 | 29.324 | 30.328 | 31.376 | 32.503 | 34.260 | 35.722 |
| Variatie | - | 0,04% | -14,04% | 3,42% | 3,46% | 3,59% | 5,4% | 4,27% |
| EBITDA 1 | 9.530 | 11.330 | 10.449 | 11.635 | 10.693 | 11.019 | 11.845 | 12.559 |
| Variatie | - | 18,89% | -7,78% | 11,35% | -8,1% | 3,05% | 7,49% | 6,03% |
| Bedrijfsresultaat (EBIT) 1 | 8.906 | 8.806 | 8.151 | 8.786 | 9.148 | 9.617 | 10.373 | 11.175 |
| Variatie | - | -1,12% | -7,44% | 7,79% | 4,12% | 5,12% | 7,87% | 7,73% |
| Betaalde rente 1 | -848 | -756 | -803 | -677 | -547 | -560,9 | -561,8 | -506,1 |
| Resultaat voor belastingen (EBT) 1 | 6.968 | 5.442 | 5.628 | 6.064 | 3.477 | 7.066 | 8.579 | 9.450 |
| Variatie | - | -21,9% | 3,42% | 7,75% | -42,66% | 103,24% | 21,4% | 10,16% |
| Nettowinst (verlies) 1 | 5.749 | 4.385 | 14.956 | 4.928 | 2.575 | 5.629 | 6.347 | 6.826 |
| Variatie | - | -23,73% | 241,07% | -67,05% | -47,75% | 118,6% | 12,76% | 7,54% |
| Datum van publicatie | 3/02/21 | 9/02/22 | 1/02/23 | 31/01/24 | 5/02/25 | - | - | - |
1GBP in Miljoen
Geschatte gegevens
Balansprognose: GSK plc
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuld 1 | 20.780 | 19.838 | 17.197 | 15.040 | 13.095 | 14.269 | 11.779 | 8.700 |
| Variatie | - | -4,53% | -13,31% | -12,54% | -12,93% | 8,97% | -17,45% | -26,14% |
| Datum van publicatie | 3/02/21 | 9/02/22 | 1/02/23 | 31/01/24 | 5/02/25 | - | - | - |
1GBP in Miljoen
Geschatte gegevens
Verwachte kasstroom: GSK plc
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 1.226 | 1.172 | 1.143 | 1.314 | 1.334 | 1.455 | 1.616 | 1.712 |
| Variatie | - | -4,4% | -2,47% | 14,96% | 1,52% | 9,05% | 11,1% | 5,93% |
| Vrije kasstroom (FCF) 1 | 5.406 | 4.437 | 6.260 | 5.454 | 5.220 | 4.648 | 6.138 | 6.646 |
| Variatie | - | -17,92% | 41,09% | -12,88% | -4,29% | -10,95% | 32,06% | 8,26% |
| Datum van publicatie | 3/02/21 | 9/02/22 | 1/02/23 | 31/01/24 | 5/02/25 | - | - | - |
1GBP in Miljoen
Geschatte gegevens
Verwachte financiële ratio's: GSK plc
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
| EBITDA-marge (%) | 27,95% | 33,21% | 35,63% | 38,36% | 34,08% | 33,9% | 34,57% | 35,16% |
| EBIT-marge (%) | 26,12% | 25,81% | 27,8% | 28,97% | 29,16% | 29,59% | 30,28% | 31,28% |
| EBT-marge (%) | 20,43% | 15,95% | 19,19% | 19,99% | 11,08% | 21,74% | 25,04% | 26,45% |
| Nettomarge (%) | 16,86% | 12,85% | 51% | 16,25% | 8,21% | 17,32% | 18,53% | 19,11% |
| FCF-marge (%) | 15,85% | 13,01% | 21,35% | 17,98% | 16,64% | 14,3% | 17,92% | 18,6% |
| Vrije kasstroom/nettoresultaat (%) | 94,03% | 101,19% | 41,86% | 110,67% | 202,72% | 82,58% | 96,71% | 97,36% |
Winstgevendheid | ||||||||
| ROA | 7,18% | 5,5% | 8,08% | 10,55% | 10,97% | 9,79% | 11,17% | 11,22% |
| ROE | 44,39% | 38,22% | 43,85% | 52,48% | 48,09% | 44,94% | 40,39% | 35,42% |
Financiële gezondheid | ||||||||
| Hefboom (schuld/ebitda) | 2,18x | 1,75x | 1,65x | 1,29x | 1,22x | 1,29x | 0,99x | 0,69x |
| Schuld/vrije kasstroom | 3,84x | 4,47x | 2,75x | 2,76x | 2,51x | 3,07x | 1,92x | 1,31x |
Kapitaalintensiteit | ||||||||
| Kapitaaluitgaven/omzet (%) | 3,6% | 3,44% | 3,9% | 4,33% | 4,25% | 4,48% | 4,72% | 4,79% |
| CAPEX / EBITDA (%) | 12,86% | 10,34% | 10,94% | 11,29% | 12,48% | 13,2% | 13,64% | 13,63% |
| CAPEX / FCF (%) | 22,68% | 26,41% | 18,26% | 24,09% | 25,56% | 31,3% | 26,33% | 25,76% |
Bestanddelen per aandeel | ||||||||
| Kasstroom per aandeel 1 | 2,094 | 1,962 | 1,813 | 1,67 | 1,608 | 1,599 | 2,068 | 2,359 |
| Variatie | - | -6,3% | -7,63% | -7,86% | -3,75% | -0,53% | 29,34% | 14,08% |
| Dividend per aandeel 1 | 1 | 1 | 0,6125 | 0,58 | 0,61 | 0,6505 | 0,6977 | 0,742 |
| Variatie | - | 0% | -38,75% | -5,31% | 5,17% | 6,63% | 7,26% | 6,36% |
| Nettoactief per aandeel 1 | 3,661 | 3,758 | 2,627 | 3,294 | 3,353 | 3,572 | 4,309 | 5,194 |
| Variatie | - | 2,65% | -30,09% | 25,38% | 1,8% | 6,51% | 20,65% | 20,53% |
| WPA 1 | 1,426 | 1,082 | 3,662 | 1,216 | 0,632 | 1,4 | 1,6 | 1,727 |
| Variatie | - | -24,1% | 238,29% | -66,79% | -48,03% | 121,52% | 14,29% | 7,93% |
| Aantal aandelen (in duizend) | 3.982.185 | 4.006.383 | 4.060.999 | 4.076.145 | 4.080.519 | 4.015.122 | 4.015.122 | 4.015.122 |
| Datum van publicatie | 3/02/21 | 9/02/22 | 1/02/23 | 31/01/24 | 5/02/25 | - | - | - |
1GBP
Geschatte gegevens
| 2025 * | 2026 * | |
|---|---|---|
| k/w-verhouding | 12,9x | 11,3x |
| PBR-ratio | 5,05x | 4,19x |
| EV/omzet | 2,67x | 2,46x |
| Dividendrendement | 3,6% | 3,87% |
Meer waarderingsratio's
* Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Trader
Trader
Beleggings
Beleggings
Globaal
Globaal
Kwaliteit van de publicaties
Kwaliteit van de publicaties
ESG MSCI
AA
Verkoop
Koop
Gemiddeld advies
Houden
Aantal analisten
20
Laatste slotkoers
18,05GBP
Gemiddelde koersdoel
18,33GBP
Spread / Gemiddelde doel
+1,55%
Kwartaalomzet - Afwijkingspercentage
Kies jouw editie
Alle financiële informatie op nationaal niveau
